MedTrace Logo

Digital Psychosocial Interventions on Stigma and Health Outcomes in TB Patients

NCT07742683 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 496

Last updated 2026-08-03

No results posted yet for this study

Summary

This study addresses the shortcomings of routine clinical management for tuberculosis (TB) patients by proposing psychosocial interventions targeting stigma, while investigating the current status of stigma, psychological issues, medication adherence, and drug resistance among tuberculosis patients. It analyzes the underlying mechanisms, integrates online mindfulness courses, digital cognitive behavioral therapy (CBT), and human-machine interactive dialogue modules to develop a digital psychosocial intervention platform. Through a randomized controlled trial, the study validates the impact of the platform on stigma and health outcomes among tuberculosis patients in China. Ultimately, the research aims to formulate a scalable digital psychosocial intervention technical solution, providing evidence-based support for optimizing China's comprehensive tuberculosis prevention and control model.

Conditions

  • Tuberculosis (TB)

Interventions

BEHAVIORAL

Online Mindfulness

The 6-week online mindfulness course developed by our research team consists of theoretical lectures plus practice audio and video materials, with 2 sessions delivered per week.

BEHAVIORAL

Online CBT Intervention

The 6-week online cbt course developed by our research team consists of 12 video materials, with 2 sessions delivered per week.

BEHAVIORAL

Human-computer Interaction

The human-computer interaction mini-program named Xiexin Xiangban, developed by the research team.

BEHAVIORAL

Routine treatment and management services provided by the tuberculosis prevention and control system

routine treatment and management services provided by the tuberculosis prevention and control system

Sponsors & Collaborators

  • Beijing Center for Disease Prevention and Control

    collaborator UNKNOWN

  • Hainan Provincial Center for Disease Control and Prevention

    collaborator UNKNOWN

  • Yichang Center for Disease Control and Prevention, China

    collaborator UNKNOWN

  • Peking Union Medical College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2027-09-30
Completion
2028-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07742683 on ClinicalTrials.gov